Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 230

1.

Ethics of randomized trials in a public health emergency.

London AJ, Omotade OO, Mello MM, Keusch GT.

PLoS Negl Trop Dis. 2018 May 17;12(5):e0006313. doi: 10.1371/journal.pntd.0006313. eCollection 2018 May. No abstract available.

2.

Reply to Jacob and Colebunders.

Ellenberg SS, Keusch GT, Babiker AG, Edwards KM, Lewis RJ, Lundgren JD, Wells CD, Wabwire-Mangen F, McAdam KPWJ.

Clin Infect Dis. 2018 Aug 31;67(6):985-986. doi: 10.1093/cid/ciy250. No abstract available.

PMID:
29590323
3.

Rigorous Clinical Trial Design in Public Health Emergencies Is Essential.

Ellenberg SS, Keusch GT, Babiker AG, Edwards KM, Lewis RJ, Lundgren JD, Wells CD, Wabwire-Mangen F, McAdam KPWJ.

Clin Infect Dis. 2018 Apr 17;66(9):1467-1469. doi: 10.1093/cid/cix1032.

4.

In search of global governance for research in epidemics.

Peters DH, Keusch GT, Cooper J, Davis S, Lundgren J, Mello MM, Omatade O, Wabwire-Mangen F, McAdam KPWJ.

Lancet. 2017 Oct 7;390(10103):1632-1633. doi: 10.1016/S0140-6736(17)32546-1. Epub 2017 Oct 5. No abstract available.

PMID:
29131784
5.

Clinical trials during epidemics.

Keusch GT, McAdam KPWJ.

Lancet. 2017 Jun 24;389(10088):2455-2457. doi: 10.1016/S0140-6736(17)31602-1. No abstract available.

PMID:
28656892
6.

Diarrheal Diseases.

Keusch GT, Walker CF, Das JK, Horton S, Habte D.

In: Black RE, Laxminarayan R, Temmerman M, Walker N, editors. Reproductive, Maternal, Newborn, and Child Health: Disease Control Priorities, Third Edition (Volume 2). Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2016 Apr 5. Chapter 9.

7.

Vitamin A deficiency: slow progress towards elimination.

Hamer DH, Keusch GT.

Lancet Glob Health. 2015 Sep;3(9):e502-3. doi: 10.1016/S2214-109X(15)00096-0. No abstract available.

8.

Environmental enteric dysfunction: pathogenesis, diagnosis, and clinical consequences.

Keusch GT, Denno DM, Black RE, Duggan C, Guerrant RL, Lavery JV, Nataro JP, Rosenberg IH, Ryan ET, Tarr PI, Ward H, Bhutta ZA, Coovadia H, Lima A, Ramakrishna B, Zaidi AK, Hay Burgess DC, Brewer T.

Clin Infect Dis. 2014 Nov 1;59 Suppl 4:S207-12. doi: 10.1093/cid/ciu485. Review.

9.

Implications of acquired environmental enteric dysfunction for growth and stunting in infants and children living in low- and middle-income countries.

Keusch GT, Rosenberg IH, Denno DM, Duggan C, Guerrant RL, Lavery JV, Tarr PI, Ward HD, Black RE, Nataro JP, Ryan ET, Bhutta ZA, Coovadia H, Lima A, Ramakrishna B, Zaidi AK, Burgess DC, Brewer T.

Food Nutr Bull. 2013 Sep;34(3):357-64. Review.

10.

Perspectives in foodborne illness.

Keusch GT.

Infect Dis Clin North Am. 2013 Sep;27(3):501-15. doi: 10.1016/j.idc.2013.05.005. Epub 2013 Jul 16. Review.

PMID:
24011827
11.

Antibiotics for uncomplicated severe malnutrition.

Okeke IN, Cruz JR, Keusch GT; Alliance for the Prudent Use of Antibiotics–Nutrition Group.

N Engl J Med. 2013 Jun 20;368(25):2435-6. doi: 10.1056/NEJMc1304407. No abstract available.

PMID:
23782190
12.

Zoonoses and marginalised infectious diseases of poverty: where do we stand?

Molyneux D, Hallaj Z, Keusch GT, McManus DP, Ngowi H, Cleaveland S, Ramos-Jimenez P, Gotuzzo E, Kar K, Sanchez A, Garba A, Carabin H, Bassili A, Chaignat CL, Meslin FX, Abushama HM, Willingham AL, Kioy D.

Parasit Vectors. 2011 Jun 14;4:106. doi: 10.1186/1756-3305-4-106.

13.

Sublingually administered Bacillus subtilis cells expressing tetanus toxin C fragment induce protective systemic and mucosal antibodies against tetanus toxin in mice.

Amuguni JH, Lee S, Kerstein KO, Brown DW, Belitsky BR, Herrmann JE, Keusch GT, Sonenshein AL, Tzipori S.

Vaccine. 2011 Jun 24;29(29-30):4778-84. doi: 10.1016/j.vaccine.2011.04.083. Epub 2011 May 10.

PMID:
21565244
14.

Shigella.

Hale TL, Keusch GT.

In: Baron S, editor. Medical Microbiology. 4th edition. Galveston (TX): University of Texas Medical Branch at Galveston; 1996. Chapter 22.

15.

Diarrheal Diseases.

Keusch GT, Fontaine O, Bhargava A, Boschi-Pinto C, Bhutta ZA, Gotuzzo E, Rivera J, Chow J, Shahid-Salles S, Laxminarayan R.

In: Jamison DT, Breman JG, Measham AR, Alleyne G, Claeson M, Evans DB, Jha P, Mills A, Musgrove P, editors. Disease Control Priorities in Developing Countries. 2nd edition. Washington (DC): World Bank; 2006. Chapter 19.

16.

Development of a Bacillus subtilis-based rotavirus vaccine.

Lee S, Belitsky BR, Brinker JP, Kerstein KO, Brown DW, Clements JD, Keusch GT, Tzipori S, Sonenshein AL, Herrmann JE.

Clin Vaccine Immunol. 2010 Nov;17(11):1647-55. doi: 10.1128/CVI.00135-10. Epub 2010 Sep 1.

17.

Efficacy, heat stability and safety of intranasally administered Bacillus subtilis spore or vegetative cell vaccines expressing tetanus toxin fragment C.

Lee S, Belitsky BR, Brown DW, Brinker JP, Kerstein KO, Herrmann JE, Keusch GT, Sonenshein AL, Tzipori S.

Vaccine. 2010 Sep 24;28(41):6658-65. doi: 10.1016/j.vaccine.2010.08.016. Epub 2010 Aug 13.

PMID:
20709005
18.

Values and moral experience in global health: bridging the local and the global.

Stewart KA, Keusch GT, Kleinman A.

Glob Public Health. 2010;5(2):115-21. doi: 10.1080/17441690903484201. No abstract available.

PMID:
20213562
19.

The global health system: lessons for a stronger institutional framework.

Moon S, Szlezák NA, Michaud CM, Jamison DT, Keusch GT, Clark WC, Bloom BR.

PLoS Med. 2010 Jan 26;7(1):e1000193. doi: 10.1371/journal.pmed.1000193. No abstract available.

20.

The global health system: linking knowledge with action--learning from malaria.

Keusch GT, Kilama WL, Moon S, Szlezák NA, Michaud CM.

PLoS Med. 2010 Jan 19;7(1):e1000179. doi: 10.1371/journal.pmed.1000179. Review. No abstract available.

21.

The global health system: actors, norms, and expectations in transition.

Szlezák NA, Bloom BR, Jamison DT, Keusch GT, Michaud CM, Moon S, Clark WC.

PLoS Med. 2010 Jan;7(1):e1000183. doi: 10.1371/journal.pmed.1000183. Epub 2010 Jan 5.

22.
23.

New challenges in studying nutrition-disease interactions in the developing world.

Prentice AM, Gershwin ME, Schaible UE, Keusch GT, Victora CG, Gordon JI.

J Clin Invest. 2008 Apr;118(4):1322-9. doi: 10.1172/JCI34034. Review.

24.

Stigma and global health: looking forward.

Michels KM, Hofman KJ, Keusch GT, Hrynkow SH.

Lancet. 2006 Feb 11;367(9509):538-9. No abstract available.

PMID:
16473135
25.

Stigma and global health: developing a research agenda.

Keusch GT, Wilentz J, Kleinman A.

Lancet. 2006 Feb 11;367(9509):525-7. No abstract available.

PMID:
16473128
26.

What do -omics mean for the science and policy of the nutritional sciences?

Keusch GT.

Am J Clin Nutr. 2006 Feb;83(2):520S-522S. Review.

PMID:
16470024
27.

Health innovation networks to help developing countries address neglected diseases.

Morel CM, Acharya T, Broun D, Dangi A, Elias C, Ganguly NK, Gardner CA, Gupta RK, Haycock J, Heher AD, Hotez PJ, Kettler HE, Keusch GT, Krattiger AF, Kreutz FT, Lall S, Lee K, Mahoney R, Martinez-Palomo A, Mashelkar RA, Matlin SA, Mzimba M, Oehler J, Ridley RG, Senanayake P, Singer P, Yun M.

Science. 2005 Jul 15;309(5733):401-4.

PMID:
16020723
28.

The multilateral initiative on malaria: past, present, and future.

Heddini A, Keusch GT, Davies CS.

Am J Trop Med Hyg. 2004 Aug;71(2 Suppl):279-82. Review. No abstract available.

PMID:
15331848
29.

Vitamin E and respiratory tract infections in elderly nursing home residents: a randomized controlled trial.

Meydani SN, Leka LS, Fine BC, Dallal GE, Keusch GT, Singh MF, Hamer DH.

JAMA. 2004 Aug 18;292(7):828-36. Erratum in: JAMA. 2004 Sep 15;292(11):1305. JAMA. 2007 May 2;297(17):1882.

30.

Spreading effective AIDS care in poor countries, thoughts on the Partners-in-Health/Zanmi Lasante experience in Haiti.

Keusch GT.

J Public Health Policy. 2004;25(2):159-61. No abstract available.

PMID:
15255382
31.

Global health, personal action.

Keusch GT.

Clin Infect Dis. 2004 Mar 15;38(6):879-80. Epub 2004 Feb 26. No abstract available.

PMID:
14999634
32.

Take HEED--if not now, when?

Keusch GT.

Environ Health Perspect. 2004 Mar;112(3):A144-5. No abstract available.

33.

Tapping the power of small institutions.

Keusch GT, Medlin CA.

Nature. 2003 Apr 10;422(6932):561-2. No abstract available.

PMID:
12686973
34.

The history of nutrition: malnutrition, infection and immunity.

Keusch GT.

J Nutr. 2003 Jan;133(1):336S-340S. Review.

PMID:
12514322
35.

The intolerable burden of malaria: a new look at the numbers.

Breman JG, Egan A, Keusch GT.

Am J Trop Med Hyg. 2001 Jan-Feb;64(1-2 Suppl):iv-vii. No abstract available.

PMID:
11425185
36.

A monkey model for enterohemorrhagic Escherichia coli infection.

Kang G, Pulimood AB, Koshi R, Hull A, Acheson D, Rajan P, Keusch GT, Mathan VI, Mathan MM.

J Infect Dis. 2001 Jul 15;184(2):206-10. Epub 2001 Jun 18.

PMID:
11424020
37.

Mediation of Cryptosporidium parvum infection in vitro by mucin-like glycoproteins defined by a neutralizing monoclonal antibody.

Cevallos AM, Bhat N, Verdon R, Hamer DH, Stein B, Tzipori S, Pereira ME, Keusch GT, Ward HD.

Infect Immun. 2000 Sep;68(9):5167-75.

38.
39.

Shiga toxins.

Acheson DW, Kane AV, Keusch GT.

Methods Mol Biol. 2000;145:41-63. No abstract available.

PMID:
10820715
40.

The potential impact of nutritional change on the global burden of viral disease.

Keusch GT.

Nutr Rev. 2000 Feb;58(2 Pt 2):S55-62. Review. No abstract available.

PMID:
10748618
41.

Quinolone antibiotics induce Shiga toxin-encoding bacteriophages, toxin production, and death in mice.

Zhang X, McDaniel AD, Wolf LE, Keusch GT, Waldor MK, Acheson DW.

J Infect Dis. 2000 Feb;181(2):664-70.

PMID:
10669353
42.

Shiga toxins 1 and 2 translocate differently across polarized intestinal epithelial cells.

Hurley BP, Jacewicz M, Thorpe CM, Lincicome LL, King AJ, Keusch GT, Acheson DW.

Infect Immun. 1999 Dec;67(12):6670-7.

43.

Shiga toxins stimulate secretion of interleukin-8 from intestinal epithelial cells.

Thorpe CM, Hurley BP, Lincicome LL, Jacewicz MS, Keusch GT, Acheson DW.

Infect Immun. 1999 Nov;67(11):5985-93.

44.

Effect of shiga toxin on NaCl transport in rat distal colon.

Krishnan S, Ramakrishna BS, Keusch GT, Acheson DW, Pulimood AB, Mathan M.

Scand J Gastroenterol. 1999 Aug;34(8):777-83.

PMID:
10499478
45.

Shiga toxins do not directly stimulate alpha-granule secretion or enhance aggregation of human platelets.

Thorpe CM, Flaumenhaft R, Hurley B, Jacewicz M, Acheson DW, Keusch GT.

Acta Haematol. 1999;102(1):51-5. No abstract available.

PMID:
10473889
46.

The rediscovery of Shiga toxin and its role in clinical disease.

Keusch GT.

Jpn J Med Sci Biol. 1998;51 Suppl:S5-22. No abstract available.

PMID:
10211432
47.

Relative influences of sex, race, environment, and HIV infection on body composition in adults.

Kotler DP, Thea DM, Heo M, Allison DB, Engelson ES, Wang J, Pierson RN Jr, St Louis M, Keusch GT.

Am J Clin Nutr. 1999 Mar;69(3):432-9.

PMID:
10075327
48.

Responses of human intestinal microvascular endothelial cells to Shiga toxins 1 and 2 and pathogenesis of hemorrhagic colitis.

Jacewicz MS, Acheson DW, Binion DG, West GA, Lincicome LL, Fiocchi C, Keusch GT.

Infect Immun. 1999 Mar;67(3):1439-44.

49.
50.

In vivo transduction with shiga toxin 1-encoding phage.

Acheson DW, Reidl J, Zhang X, Keusch GT, Mekalanos JJ, Waldor MK.

Infect Immun. 1998 Sep;66(9):4496-8.

Supplemental Content

Loading ...
Support Center